Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, University College London, London, United Kingdom.
Cancer Discov. 2021 Oct;11(10):2456-2473. doi: 10.1158/2159-8290.CD-20-0725. Epub 2021 May 4.
APOBEC3 enzymes are cytosine deaminases implicated in cancer. Precisely when expression is induced during cancer development remains to be defined. Here we show that specific genes are upregulated in breast ductal carcinoma , and in preinvasive lung cancer lesions coincident with cellular proliferation. We observe evidence of APOBEC3-mediated subclonal mutagenesis propagated from TRACERx preinvasive to invasive non-small cell lung cancer (NSCLC) lesions. We find that APOBEC3B exacerbates DNA replication stress and chromosomal instability through incomplete replication of genomic DNA, manifested by accumulation of mitotic ultrafine bridges and 53BP1 nuclear bodies in the G phase of the cell cycle. Analysis of TRACERx NSCLC clinical samples and mouse lung cancer models revealed expression driving replication stress and chromosome missegregation. We propose that APOBEC3 is functionally implicated in the onset of chromosomal instability and somatic mutational heterogeneity in preinvasive disease, providing fuel for selection early in cancer evolution. SIGNIFICANCE: This study reveals the dynamics and drivers of gene expression in preinvasive disease and the exacerbation of cellular diversity by APOBEC3B through DNA replication stress to promote chromosomal instability early in cancer evolution..
APOBEC3 酶是参与癌症的胞嘧啶脱氨酶。在癌症发展过程中确切何时诱导表达仍有待确定。在这里,我们表明在乳腺导管癌和与细胞增殖一致的肺癌前病变中,特定的 基因上调。我们观察到 APOBEC3 介导的亚克隆突变从 TRACERx 前侵袭性到侵袭性非小细胞肺癌(NSCLC)病变传播的证据。我们发现 APOBEC3B 通过基因组 DNA 的不完全复制加剧 DNA 复制应激和染色体不稳定性,表现为有丝分裂超细桥和 53BP1 核体在细胞周期的 G 期积累。对 TRACERx NSCLC 临床样本和小鼠肺癌模型的分析表明, 表达驱动复制应激和染色体错分。我们提出 APOBEC3 在侵袭前疾病中染色体不稳定性和体细胞突变异质性的发生中具有功能意义,为癌症进化早期的选择提供了燃料。意义:本研究揭示了 APOBEC3 在侵袭前疾病中的 基因表达动态及其通过 DNA 复制应激加剧 APOBEC3B 细胞多样性的驱动力,以促进癌症进化早期的染色体不稳定性。